PD-012Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

ABSTRACT:

SUBMITTER: Van Cutsem E 

PROVIDER: S-EPMC4984160 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature